Clinical trial · Observational
Ovarian Screening Study
The University of Louisville Ovarian Screening Study
NCT00267072CI-TRIAL-00031078completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objectives of this study are: * To identify women at increased risk for developing ovarian cancer * To detect ovarian cancers at an early stage * To investigate the role of tumor membrane fragments as tumor markers for early ovarian carcinoma
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Asymptomatic women over the age of 45 with one or both ovaries. * Women over the age of 25 with one or both ovaries and any of the following: * A personal history of breast, colon or endometrial cancer or breast cancer gene (BRCA) 1 or 2 positive * First-degree relative (mother, sister, daughter) with ovarian or breast cancer * Two family members with either breast and/or ovarian cancer * Mother, sister, daughter, grandparent with a positive BRCA1 or BRCA2 genetic test result. * Past use of fertility drugs such as Clomid or Pergonal for more than a year. Exclusion Criteria: * Women who are symptomatic of ovarian cancer
References
Publications (1)
- BACKGROUNDGreenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001 Jan-Feb;51(1):15-36. doi: 10.3322/canjclin.51.1.15. PMID 11577478